
Dec 19th, 2022
WE-Spark Health Institute inaugurated its leadership awards.
A research team is studying the use of nanoparticles to target and treat the aggressive brain cancer glioblastoma.
WE-Spark Health Institute details its accomplishments in its third annual Impact Report.
WE-Spark Health Institute has awarded more than $1 million in research grants.